JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/16.01.26 Stock

Warrant

DE000JK50Z80

Market Closed - Börse Stuttgart 03:04:10 2024-06-07 EDT
0.11 EUR 0.00% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/16.01.26
Current month+17.02%
1 month-31.25%
Date Price Change
24-06-07 0.11 0.00%
24-06-06 0.11 +14.58%
24-06-05 0.096 -4.00%
24-06-04 0.1 -9.09%
24-06-03 0.11 +17.02%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 03:04 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK50Z8
ISINDE000JK50Z80
Date issued 2024-04-04
Strike 160 $
Maturity 2026-01-16 (586 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.27
Lowest since issue 0.084
Delta0.14x
Omega 7.719
Premium50.48x
Gearing56.91x
Moneyness 0.6724
Difference Strike 52.42 $
Difference Strike %+32.76%
Spread 0.05
Spread %25.00%
Theoretical value 0.1750
Implied Volatility 22.58 %
Total Loss Probability 91.40 %
Intrinsic value 0.000000
Present value 0.1750
Break even 161.89 €
Theta-0x
Vega0.03x
Rho0.02x

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
107.6 USD
Average target price
125.4 USD
Spread / Average Target
+16.54%
Consensus